TGF-β Signaling in Cancer: Mechanisms of Progression and Therapeutic Targets

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals TGF-β drives cancer progression through pathways like EMT, suggesting potential therapeutic targets.

Disrupting tgf-β signaling contributes to cancer development and progression, indicating a key therapeutic area.
TGF-β initially inhibits the cell cycle but may later promote tumor growth and metastasis, highlighting its dual role.
Targeting tgf-β with pharmacological agents has emerged as a promising therapeutic strategy, improving treatment effectiveness.
Understanding the mechanisms of tgf-β signaling is crucial for enhancing survival rates in cancer patients; ongoing research is vital.

Cecerska‐Heryć et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals TGF-β drives cancer progression through pathways like EMT, suggesting potential therapeutic targets.

Disrupting tgf-β signaling contributes to cancer development and progression, indicating a key therapeutic area.
TGF-β initially inhibits the cell cycle but may later promote tumor growth and metastasis, highlighting its dual role.
Targeting tgf-β with pharmacological agents has emerged as a promising therapeutic strategy, improving treatment effectiveness.
Understanding the mechanisms of tgf-β signaling is crucial for enhancing survival rates in cancer patients; ongoing research is vital.

Cecerska‐Heryć et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark